1.78
                                            
            Bluejay Diagnostics Inc stock is traded at $1.78, with a volume of 51,319.
            It is down -9.64% in the last 24 hours and up +15.58% over the past month.
            Bluejay Diagnostics Inc is a medical diagnostics company focused on improving patient outcomes using its Symphony System, a cost-effective, rapid, near-patient testing system for sepsis triage and monitoring of disease progression. Bluejay's first product candidate, an IL-6 Test for sepsis, is designed to provide accurate, reliable results in approximately 20 minutes from 'sample-to-result' to help medical professionals make earlier and better triage/treatment decisions.
        
        See More
    Previous Close:
              $1.97
            Open:
              $1.97
            24h Volume:
                51,319
            Relative Volume:
              0.01
            Market Cap:
                $2.66M
            Revenue:
              -
            Net Income/Loss:
              $-8.59M
            P/E Ratio:
              -0.0013
            EPS:
                -1373
            Net Cash Flow:
                $-9.25M
            1W Performance:
              -21.93%
            1M Performance:
              +15.58%
            6M Performance:
                -7.29%
            1Y Performance:
              -57.57%
            Bluejay Diagnostics Inc Stock (BJDX) Company Profile
Name
                  
                      Bluejay Diagnostics Inc
                    
                Sector
                  Industry
                  Phone
                  
                      (978) 631-0152
                    
                Address
                  
                      360 MASSACHUSETTS AVENUE, SUITE 203, ACTON
                    
                Compare BJDX with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS | 
|---|---|---|---|---|---|---|
| 
                         
                          
                                BJDX
                            
                             
                        Bluejay Diagnostics Inc 
                           | 
                    1.78 | 3.29M | 0 | -8.59M | -9.25M | -1,373.00 | 
| 
                         
                          
                                ABT
                            
                             
                        Abbott Laboratories 
                           | 
                    123.84 | 214.96B | 43.84B | 13.90B | 6.92B | 7.9725 | 
| 
                         
                          
                                BSX
                            
                             
                        Boston Scientific Corp 
                           | 
                    98.59 | 149.24B | 19.35B | 2.78B | 3.49B | 1.8696 | 
| 
                         
                          
                                SYK
                            
                             
                        Stryker Corp 
                           | 
                    358.16 | 136.23B | 24.38B | 2.94B | 4.07B | 7.6159 | 
| 
                         
                          
                                MDT
                            
                             
                        Medtronic Plc 
                           | 
                    90.20 | 116.33B | 34.20B | 4.69B | 5.30B | 3.6218 | 
| 
                         
                          
                                EW
                            
                             
                        Edwards Lifesciences Corp 
                           | 
                    83.07 | 48.41B | 5.88B | 1.34B | 577.90M | 2.3455 | 
Bluejay Diagnostics Inc Stock (BJDX) Latest News
Analyzing drawdowns of Bluejay Diagnostics Inc. with statistical toolsPortfolio Value Report & Accurate Trade Setup Notifications - newser.com
Is Bluejay Diagnostics Inc. stock a top pick in earnings seasonChart Signals & Proven Capital Preservation Tips - newser.com
Custom watchlist performance reports with Bluejay Diagnostics Inc.Gap Up & Safe Entry Trade Signal Reports - newser.com
Tick level data insight on Bluejay Diagnostics Inc. volatilityQuarterly Trade Review & Real-Time Market Sentiment Reports - newser.com
Risk adjusted return profile for Bluejay Diagnostics Inc. analyzedJuly 2025 Pullbacks & Safe Entry Point Identification - newser.com
Statistical indicators supporting Bluejay Diagnostics Inc.’s strengthJuly 2025 Highlights & Real-Time Volume Analysis - newser.com
Published on: 2025-11-03 03:50:43 - newser.com
How Bluejay Diagnostics Inc. stock reacts to oil pricesQuarterly Risk Review & Weekly Momentum Stock Picks - newser.com
How geopolitical tensions affect Bluejay Diagnostics Inc. stockPortfolio Value Summary & Advanced Swing Trade Entry Alerts - newser.com
Why Bluejay Diagnostics Inc. stock remains on watchlistsWeekly Trade Analysis & Risk Controlled Daily Trade Plans - newser.com
Can Bluejay Diagnostics Inc. stock beat analyst upgradesDollar Strength & High Conviction Investment Ideas - newser.com
What Wall Street predicts for Bluejay Diagnostics Inc. stock priceEntry Point & Smart Investment Allocation Insights - newser.com
Is Bluejay Diagnostics Inc. stock a safe buy before earningsInsider Buying & Comprehensive Market Scan Insights - newser.com
Bluejay Diagnostics Inc. (BJDX) Stock Price | Live Quotes & Charts | NSC - StocksToTrade
Will Bluejay Diagnostics Inc. stock maintain dividend yieldTrend Reversal & Trade Opportunity Analysis - newser.com
Applying chart zones and confluence areas to Bluejay Diagnostics Inc.Gap Down & AI Powered Trade Plan Recommendations - newser.com
Will Bluejay Diagnostics Inc. stock maintain momentum in 2025July 2025 Analyst Calls & Weekly Chart Analysis and Trade Guides - newser.com
Published on: 2025-10-30 05:00:02 - newser.com
Published on: 2025-10-29 06:45:20 - newser.com
Bluejay Diagnostics Inc Stock (BJDX) Financials Data
Revenue
Net Income
Cash Flow
EPS
        Open in Yahoo
        |
        Open in Google
            |
            Open in Finviz
        |
        Open in MarketWatch
            |
            Open in EDGAR    
        |
        Open in Reuters
    
    
                Cap:
                 
                  | 
                Volume (24h):